[go: up one dir, main page]

GB0215591D0 - Formulation - Google Patents

Formulation

Info

Publication number
GB0215591D0
GB0215591D0 GB0215591A GB0215591A GB0215591D0 GB 0215591 D0 GB0215591 D0 GB 0215591D0 GB 0215591 A GB0215591 A GB 0215591A GB 0215591 A GB0215591 A GB 0215591A GB 0215591 D0 GB0215591 D0 GB 0215591D0
Authority
GB
United Kingdom
Prior art keywords
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0215591A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
King Roderick F G
Original Assignee
King Roderick F G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King Roderick F G filed Critical King Roderick F G
Priority to GB0215591A priority Critical patent/GB0215591D0/en
Publication of GB0215591D0 publication Critical patent/GB0215591D0/en
Priority to PCT/GB2003/002914 priority patent/WO2004004740A1/en
Priority to AU2003281195A priority patent/AU2003281195A1/en
Ceased legal-status Critical Current

Links

GB0215591A 2002-07-05 2002-07-05 Formulation Ceased GB0215591D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0215591A GB0215591D0 (en) 2002-07-05 2002-07-05 Formulation
PCT/GB2003/002914 WO2004004740A1 (en) 2002-07-05 2003-07-07 Aqueous formulation comprising digestible saccharides to reduce the tendency to cardiovascular disease in a subject
AU2003281195A AU2003281195A1 (en) 2002-07-05 2003-07-07 Aqueous formulation comprising digestible saccharides to reduce the tendency to cardiovascular disease in a subject

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0215591A GB0215591D0 (en) 2002-07-05 2002-07-05 Formulation

Publications (1)

Publication Number Publication Date
GB0215591D0 true GB0215591D0 (en) 2002-08-14

Family

ID=9939913

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0215591A Ceased GB0215591D0 (en) 2002-07-05 2002-07-05 Formulation

Country Status (1)

Country Link
GB (1) GB0215591D0 (en)

Similar Documents

Publication Publication Date Title
DE60311980D1 (en) Histondeacetylase-hemmer
DE60319515D1 (en) Delta-sigma-modulator
EP1466407A4 (en) Modulator- amplifier
GB0206048D0 (en) Use
GB0227666D0 (en) Use
AU2003252028A8 (en) Heterodiamondoids
GB0319874D0 (en) Novel formulation
DE60326439D1 (en) Npolymer
GB0207438D0 (en) Formulation
AU2003279495A8 (en) Alert-modeling
GB0205504D0 (en) Formulation
GB0318448D0 (en) Formulation
GB0217056D0 (en) Use
DE50312412D1 (en) 4-hydroxymethyl-1-aryl-cyclohexylamin-derivative
DE60224584D1 (en) Rotationsdämpfer
GB0213878D0 (en) Use
GB0312195D0 (en) Formulation
DE50310169D1 (en) Lingual-retainer
GB0320522D0 (en) Formulation
GB0206838D0 (en) Use
AU2003262681A8 (en) Hemo-aide
GB0303876D0 (en) Formulation
GB0214147D0 (en) Formulations
GB0230343D0 (en) Use
AU2003253735A8 (en) Vacuolins

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)